Microbix Biosystems Inc. (MBX.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
At close: 03:55PM EDT
| Previous Close | 0.5100 |
| Open | 0.5000 |
| Bid | 0.4950 x 0 |
| Ask | 0.5000 x 0 |
| Day's Range | 0.4950 - 0.5000 |
| 52 Week Range | 0.4200 - 0.8700 |
| Volume | |
| Avg. Volume | 33,664 |
| Market Cap | 70.177M |
| Beta (5Y Monthly) | 0.19 |
| PE Ratio (TTM) | 24.75 |
| EPS (TTM) | 0.0200 |
| Earnings Date | Dec 21, 2022 - Dec 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Sept 02, 1999 |
| 1y Target Est | 1.13 |
- Baystreet
Stocks in play: Microbix Biosystems Inc.
Announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian ...
- Simply Wall St.
Is Microbix Biosystems Inc.'s (TSE:MBX) Latest Stock Performance Being Led By Its Strong Fundamentals?
Microbix Biosystems' (TSE:MBX) stock is up by 4.1% over the past three months. Given its impressive performance, we...
- GlobeNewswire
Microbix Presenting Test-Workflow Validation Results at EMMD
MSwab® & PROCEEDx™FLOQ® Supporting Self-Collection for HPV Screening ProgramsMISSISSAUGA, Ontario, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the Australian Centre for the Prevention of Cervical Cancer (VCS Pathology), it will present results of novel methods to s
© 2022 Yahoo. All rights reserved.
